Similar and Different Regional Homogeneity Changes Between Bipolar Disorder and Unipolar Depression: A Resting-State fMRI Study.

bipolar depression regional homogeneity rs-fMRI unipolar depression

Journal

Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304

Informations de publication

Date de publication:
2020
Historique:
received: 12 02 2020
accepted: 09 04 2020
entrez: 20 5 2020
pubmed: 20 5 2020
medline: 20 5 2020
Statut: epublish

Résumé

To investigate the regional homogeneity (ReHo) between unipolar depression (UD) and bipolar disorder (BD), and to search for brain imaging markers for distinguishing UD and BD. A total of 58 patients who met the diagnosis criteria of UD in DSM-Ⅳ, 40 patients who met the diagnosis criteria of BD in DSM-Ⅳ and 54 healthy controls (HC) completed the resting-state functional magnetic resonance (rs-fMRI) scans. The ReHo of the three groups was compared and Pearson correlation analysis was performed between the ReHo values and the clinical symptoms. (1) Significant differences were found in the right hippocampus, right parahippocampal gyrus, right Inferior orbitofrontal gyrus, right superior temporal gyrus, right inferior temporal gyrus, and right middle occipital gyrus across the three groups. (2) Compared to HC, the ReHo in the right parahippocampal gyrus in UD significantly increased. (3) When compared to HC, the ReHo in the right hippocampus in BD significantly increased. The ReHo in the right middle occipital gyrus decreased. (4) Compared to UD, BD exhibited significantly decreased ReHo in the right inferior temporal gyrus. No correlations were observed between the scores of 24-item Hamilton Depression Rating Scale (HDMD-24), Hamilton Anxiety Scale (HAMA), Young Mania Rating Scale (YMRS), and the ReHo values of altered brain regions between BD and UD. The results suggest that there was a considerable difference in the ReHo of brain among UD, BD, and HCs. ReHo in the right inferior temporal gyrus showed significant differences between BD and UD that might serve as neuroimaging markers to identify BD and UD.

Identifiants

pubmed: 32425537
doi: 10.2147/NDT.S249489
pii: 249489
pmc: PMC7196208
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1087-1093

Informations de copyright

© 2020 Liu et al.

Déclaration de conflit d'intérêts

All authors declare that they have no conflicts of interest.

Références

Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15861-15870
pubmed: 31332015
Bipolar Disord. 2016 Nov;18(7):571-582
pubmed: 27813234
J Affect Disord. 2009 Jun;115(3):430-8
pubmed: 19007997
PLoS One. 2013 Dec 04;8(12):e79999
pubmed: 24324588
J Affect Disord. 2013 May 15;148(1):129-35
pubmed: 23219059
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Apr 20;91:20-27
pubmed: 29601896
Brain. 2007 Aug;130(Pt 8):2085-96
pubmed: 17533167
Synapse. 2018 Feb;72(2):
pubmed: 28960527
Neuroimage. 2013 Jan 15;65:374-86
pubmed: 23085497
J Psychiatr Res. 2018 Jun;101:57-62
pubmed: 29550609
Transl Psychiatry. 2016 Nov 8;6(11):e942
pubmed: 27824357
Neurosci Lett. 2018 Apr 23;673:28-32
pubmed: 29466722
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Mar 5;41:52-9
pubmed: 23200830
J Affect Disord. 2016 Jan 15;190:483-493
pubmed: 26551408
Neuroinformatics. 2016 Jul;14(3):339-51
pubmed: 27075850
Arch Gen Psychiatry. 1995 Feb;52(2):114-23
pubmed: 7848047
Biol Psychiatry. 2016 Feb 15;79(4):293-302
pubmed: 25891219
Bipolar Disord. 2015 Aug;17(5):486-95
pubmed: 26241359
Psychol Med. 2006 May;36(5):609-18
pubmed: 16469198
Lancet. 2016 Apr 9;387(10027):1561-1572
pubmed: 26388529
Br J Pharmacol. 2017 Oct;174(19):3211-3225
pubmed: 28477384
J Clin Psychiatry. 2003 Feb;64(2):161-74
pubmed: 12633125
Front Syst Neurosci. 2010 May 14;4:13
pubmed: 20577591
Curr Med Res Opin. 2004;20(2):139-54
pubmed: 15006007
Int J Geriatr Psychiatry. 2019 Jan;34(1):186-192
pubmed: 30328161
J Clin Psychiatry. 2012 Feb;73(2):e271-6
pubmed: 22401488
J Int Neuropsychol Soc. 2011 Nov;17(6):1080-93
pubmed: 22013998
Neuropsychiatr Dis Treat. 2014 Feb 17;10:317-23
pubmed: 24570585

Auteurs

Penghong Liu (P)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.
Department of Psychiatry, Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Qi Li (Q)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.
Department of Psychiatry, Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Aixia Zhang (A)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Zhifen Liu (Z)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Ning Sun (N)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Chunxia Yang (C)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Yanfang Wang (Y)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Kerang Zhang (K)

Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, People's Republic of China.

Classifications MeSH